Paysign (NASDAQ:PAYS) Sets New 1-Year High – Here’s What Happened

Paysign, Inc. (NASDAQ:PAYS) reached a new 52-week high during trading on Thursday. The company traded as high as $15.09 and last traded at $14.95, with a volume of 873,426 shares trading hands. The stock had previously closed at $14.36.

Wall Street Analyst Weigh In

PAYS has been the subject of a number of research analyst reports. Lake Street Capital upped their target price on Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a research report on Tuesday, September 15th. DA Davidson upped their price target on shares of Paysign from $12.00 to $15.00 and gave the company a “buy” rating in a report on Wednesday, September 30th. Weiss Ratings raised shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday. Wall Street Zen downgraded shares of Paysign from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 16th. Finally, Barrington Research set a $15.00 target price on Paysign in a report on Tuesday, August 11th. Three research analysts have rated the stock with a Buy rating. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $15.00.

Paysign Stock Up 2.7%

The firm has a 50-day moving average price of $12.99 and a two-hundred day moving average price of $9.11. The company has a market capitalization of $867.79 million, a P/E ratio of 59.12 and a beta of 0.83.

Paysign (NASDAQ:PAYS) last posted its earnings results on Wednesday, August 5th. The company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.05. The business had revenue of $28.25 million for the quarter, compared to analysts’ expectations of $26.36 million. Paysign had a net margin of 15.67% and a return on equity of 30.13%. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. On average, analysts predict that Paysign, Inc. will post 0.58 EPS for the current fiscal year.

Insider Buying and Selling

In other Paysign news, CEO Mark Newcomer sold 150,000 shares of the stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $11.88, for a total value of $1,782,000.00. Following the sale, the chief executive officer directly owned 9,163,002 shares in the company, valued at approximately $108,856,463.76. This trade represents a 1.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael C. Ngo sold 79,925 shares of Paysign stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $12.74, for a total transaction of $1,018,244.50. Following the transaction, the insider directly owned 2,350,000 shares in the company, valued at approximately $29,939,000. This represents a 3.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 444,904 shares of company stock worth $5,328,124 in the last ninety days. 24.50% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Paysign

Institutional investors have recently modified their holdings of the business. Legal & General Group Plc bought a new position in Paysign during the 2nd quarter worth about $35,000. Caitong International Asset Management Co. Ltd grew its position in shares of Paysign by 381.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 9,876 shares of the company’s stock valued at $51,000 after acquiring an additional 7,825 shares during the period. EFG International AG acquired a new position in Paysign during the second quarter worth approximately $68,000. Quantbot Technologies LP bought a new position in Paysign during the second quarter worth $97,000. Finally, The Manufacturers Life Insurance Company acquired a new position in shares of Paysign in the second quarter valued at approximately $100,000. Institutional investors own 25.89% of the company’s stock.

Paysign Company Profile

Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.

The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.